Resource Use and Outcomes in Critically Ill Patients with Blood Cancer
Author Information
Author(s): Tobias M. Merz, Pascale Schär, Michael Bühlmann, Jukka Takala, Hans U. Rothen
Primary Institution: Bern University Hospital
Hypothesis
The study aims to assess the amount of intensive care resources needed for hemato-oncological patients compared to nononcological patients with similar organ dysfunction.
Conclusion
Hemato-oncological patients use more ICU resources but do not have higher mortality rates compared to nononcological patients.
Supporting Evidence
- Hemato-oncological patients had a median TISS-28 score of 214 compared to 95 for nononcological patients.
- ICU mortality rates were similar for hemato-oncological and nononcological patients with comparable SAPS scores.
- Improvement in organ function within the first 48 hours was the best predictor of 28-day survival.
Takeaway
Patients with blood cancer in the ICU need more help and resources, but they don't die more often than other patients with similar problems.
Methodology
A retrospective cohort study comparing 101 hemato-oncological ICU admissions with 3,808 nononcological ICU admissions over four years.
Potential Biases
Potential bias due to the single-center design and exclusion of patients not admitted to the ICU.
Limitations
The study is retrospective and has a relatively small patient population.
Participant Demographics
The study included 84 hemato-oncological patients with a primary diagnosis of leukemia, lymphoma, or myeloma.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website